Synopses & Reviews
This book provides insight into an intriguing group of rare cancers. Neuroendocrine Tumors covers the surge of recent advances in genetics and molecular biology and offers instruction into new modalities in treatment. International authorities present a comprehensive review of the epidemiology, biology, and management of Neuroendocrine tumors. With emerging data from the latest clinical trials, special attention is given to chemotherapy, surgical management, and novel agents for early and high grade NET. The rising incidence of these fascinating hormone secreting tumors makes this volume essential reading for medical oncologists, surgeons, gastroenterologists, and endocrinologists.
Review
From the reviews: "This text is a welcome addition to the Current Clinical Oncology series ... . The book is extremely broad in its coverage and does include just about all of the neuroendocrine tumours ... . as a handy lightweight reference it is an extremely useful addition both to the hospital library and the personal library of clinicians who manage these tumours. ... it is a very readable reference book and a great asset to the library ... ." (Nick Reed, Oncology News, Vol. 6 (6), January/February, 2012)
Review
From the reviews:
"This text is a welcome addition to the Current Clinical Oncology series ... . The book is extremely broad in its coverage and does include just about all of the neuroendocrine tumours ... . as a handy lightweight reference it is an extremely useful addition both to the hospital library and the personal library of clinicians who manage these tumours. ... it is a very readable reference book and a great asset to the library ... ." (Nick Reed, Oncology News, Vol. 6 (6), January/February, 2012)
"Individual chapters are discussing the epidemiology and pathology of neuroendocrine tumors as well as problems of multiple endocrine neoplasia (MEN syndrome). Special attention is paid to other genetic syndromes such as von Hippel Lindau syndrome, neurofibromatosis, tuberous sclerosis and paraganglioma-phaechromocytoma. ... the editors and authors hope that their work will help to demystify some important misconceptions regarding neuroendocrione tumors and that it maz help to improve the treatment of patients and families affected by this disease." (Endocrine Regulations, January, 2012)
Synopsis
New research has shown that neuroendocrine tumors are more common than previously thought. Progress in our understanding of the molecular pathogenesis of these not-so-rare cancers has resulted in renewed interest in developinginnovative therapeutic options. In particular, novel molecular targeted agents have been shown to have significant anti-tumor activity, and integration of these therapies has led to critical advances in management.
In this volume, an outstanding group of the world s leaders in the field have assembled to convey their knowledge of the epidemiology, biology, and management of allthemajor types of neuroendocrine tumors. The book takes a multi-modality approach to understanding disease processes and therapeutics, including chapters on medical and surgical treatment as well as a chapter devoted to imaging. Throughout, the authors emphasize recent advances in our understanding of molecular biology and the subsequent emerging therapeutic options."
Synopsis
This book offers insight into an intriguing group of rare cancers, examining a surge of recent advances in genetics and molecular biology, and offering instruction in new modalities of treatment. Coverage includes chemotherapy, surgical management, and more.
Synopsis
New research has shown that neuroendocrine tumors are more common than previously thought.
Table of Contents
1. Global Epidemiology of Neuroendocrine Tumors 2. Pathology 3. Multiple Endocrine Neoplasia 4. Other Genetic Syndromes (TSC, VHL, NF-1,...) 5. Imaging of Neuroendocrine Tumors 6. Surgical Management of Sporadic Gastrointestinal Neuroendocrine Tumors 7. Management of Neuroendocrine Tumor Hormonal Syndromes 8. Management of Metastatic Carcinoid Tumors 9. Medical Management of Islet Cell Carcinoma 10. Poorly Differentiated Neuroendocrine Tumors 11. Hereditary and Sporadic Medullary Thyroid Carcinoma 12. Adrenocortical Carcinoma 13. Pheochromocytoma 14. Merkel Cell Carcinoma